---
layout: posts
permalink: /sources/
title: Sources
---

Mechanisms of egfr Gene Transcription Modulation: Relationship to Cancer Risk and Therapy Response. Burkhard Brandt, Sönke Meyer-Staeckling, Hartmut Schmidt, Konstantin Agelopoulos, Horst Buerger. 15 December 2006. Clinical Cancer Research Volume 12 Issue 24 
https://doi.org/10.1158/1078-0432.CCR-06-0626

Zhen Y, Guanghui L, Xiefu Z. Knockdown of EGFR inhibits growth and invasion of gastric cancer cells. Cancer Gene Ther. 2014 Nov;21(11):491-7. doi: 10.1038/cgt.2014.55. Epub 2014 Nov 14. PMID: 25394504. https://doi.org/10.1038/cgt.2014.55


​​Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer
https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing/egfr


Mechanisms of egfr Gene Transcription Modulation: Relationship to Cancer Risk and Therapy Response. Burkhard Brandt, Sönke Meyer-Staeckling, Hartmut Schmidt, Konstantin Agelopoulos, Horst Buerger. 15 December 2006. Clinical Cancer Research Volume 12 Issue 24


Herbst RS (2004). "Review of epidermal growth factor receptor biology". International Journal of Radiation Oncology, Biology, Physics


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420791/


https://www.omim.org/entry/131550


https://www.creative-diagnostics.com/egf-egfr-signaling-pathway.htm

Martin, Petra & Kelly, Catherine & Carney, Desmond. (2006). Epidermal Growth Factor Receptor-Targeted Agents for Lung Cancer. Cancer control : journal of the Moffitt Cancer Center. 13. 129-40. 10.1177/107327480601300207. 